| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 538.76M | 468.46M | 193.77M | 357.15M | 382.27M | 411.86M |
| Gross Profit | 9.30M | 17.30M | -7.15M | 7.33M | -29.92M | -9.05M |
| EBITDA | 175.50K | 12.22M | -56.41M | 1.14M | -62.53M | -49.64M |
| Net Income | 1.76M | 9.87M | -59.28M | -969.00K | 40.10M | -245.03M |
Balance Sheet | ||||||
| Total Assets | 166.01M | 169.40M | 196.53M | 226.86M | 240.88M | 407.06M |
| Cash, Cash Equivalents and Short-Term Investments | 5.37M | 32.60M | 35.21M | 31.59M | 9.55M | 37.92M |
| Total Debt | 20.29M | 10.01M | 12.92M | 599.00K | 4.38M | 12.01M |
| Total Liabilities | 171.72M | 169.94M | 206.95M | 177.99M | 190.98M | 404.75M |
| Stockholders Equity | -5.71M | -548.00K | -10.42M | 48.87M | 49.78M | 27.37M |
Cash Flow | ||||||
| Free Cash Flow | -10.43M | -27.30M | -19.92M | 31.51M | -29.92M | -100.45M |
| Operating Cash Flow | -10.36M | -27.25M | -19.77M | 32.20M | -29.67M | -99.43M |
| Investing Cash Flow | 2.45M | 16.29M | -2.51M | -16.73M | 27.64M | 9.01M |
| Financing Cash Flow | 1.21M | 871.00K | 25.90M | 5.18M | -10.53M | -60.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | HK$102.00M | 10.59 | 4.53% | ― | -40.54% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | HK$64.50M | -3.64 | -14.78% | ― | -28.21% | 34.59% | |
50 Neutral | HK$59.00M | -4.24 | -4.84% | ― | 71.16% | -67.47% | |
49 Neutral | HK$81.60M | 136.00 | 0.18% | ― | -2.05% | ― | |
44 Neutral | HK$127.87M | -250.00 | ― | ― | 11.52% | 98.72% | |
43 Neutral | HK$78.65M | -2.44 | -19.00% | ― | 48.86% | 54.49% |
FDB Holdings Limited has announced a supplementary disclosure related to its 2024 Annual Report. The company has clarified that a maximum of 133,200,000 shares, representing 10% of the total shares, may be issued upon the exercise of options under its scheme. As of the end of 2024, no share options have been granted, and the available options for grant remain at 133,200,000 shares. This disclosure does not affect any other information in the annual report.